Siezta 100 Mg Sildenafil Oral Strips

A study conducted in Japan surveyed 25 patients with ED regarding the

• Sildenafil oral strips are a fast-acting form of erectile dysfunction medication.
• They are administered orally, dissolving quickly on the tongue for rapid effect.
• Sildenafil strips are often flavored to improve the user experience.
• They contain the same active ingredient as traditional sildenafil tablets.
• These strips are designed for people seeking discreet medication options.
• Onset of action for sildenafil strips can be within 15-30 minutes.
• Proper storage of sildenafil strips involves keeping them in a cool, dry place.
• Dosage strength varies, typically available in 25mg, 50mg, and 100mg.
• Using sildenafil strips without medical consultation is not recommended.
• They may interact with other medications like nitrates or alpha-blockers.
• Sildenafil oral strips are approved for the treatment of erectile dysfunction.
• Users should follow prescribed dosages for safety and effectiveness.

ease of consumption and portability with the use of sildenafil ODF formulation.

Adverse effects

The bioequivalence was demonstrated as the resultant ratios were within the approved range of 80% to 125%. Furthermore, the pharmacokinetic parameters in the successive study also established the bioequivalence for sildenafil citrate ODF (without water) with that of sildenafil citrate FCT with water. The ratios of adjusted geometric means (90% CI) were maximum plasma concentration: 1.02 (95.47–109.36) and area under the plasma concentration–time curve: 1.06 (103.42–108.40) for sildenafil citrate ODF without water vs sildenafil citrate FCT with water. The occurrence of adverse events was observed at similar rates for both the formulations in all the studies, which were of mild intensity. The study results demonstrated the bioequivalence and supported the interchangeability of new sildenafil citrate ODF formulation with the marketed FCT formulation [Citation76].

4.1 Nitrates

The usage of ODFs is convenient among patients due to its durability, ease of administration with no suffocation risk, and ease of carrying the strips without the need for a secondary container [Citation8]. Among other advantages, the sildenafil ODF offers unique benefit to patients with ED in respecting their privacy. While the shame and the stigma culturally linked to the ED management is considered a major unmet need of the patients treated with phosphodiesterase 5 inhibitors (PDE5-Is), the ODF allows them to carry the drug in their pockets, in the most discreet way, and then be placed on the tongue before engaging in sexual activity [Citation8,Citation77,Citation78]. Furthermore, the absence of the need to swallow the drug with water further increases the ease of use and the potential reduction of the stigma of being treated with a traditional pill. In fact, when the film is placed upon the tongue or in the oral cavity, it gets immediately hydrated by saliva without any need of water followed by rapid disintegration and drug release for oro-mucosal and/or systemic absorption [Citation76]. The survey items comprised (i) portability, (ii) storage techniques, (iii)

• Sildenafil oral strips provide a non-invasive way to treat ED.
• They avoid swallowing pills, which some patients find difficult.
• Strips are often manufactured with pleasant flavors to enhance appeal.
• The medication’s effect can be influenced by food intake.
• Alcohol consumption may reduce effectiveness or increase side effects.
• Sildenafil strips should be used as prescribed and not mixed with other ED drugs.
• These strips are designed for quick absorption in the oral mucosa.
• Overuse or misuse can lead to adverse health effects.
• Proper dosing helps minimize risks of prolonged erections or priapism.
• Sildenafil strips do not cure ED but help manage symptoms.
• They may be used in combination with psychological or lifestyle interventions.
• Always check expiration dates before using sildenafil strips.

ease of consumption, (iv) comfortableness, (v) extent of self-consciousness with

Product	Dosage	Quantity + Bonus	Price
Kamagra Soft Tabs	100mg	120 + 6 Pills	311.78€ 296.93€	Buy
Kamagra Polo	100mg	120 + 6 Pills	327.15€ 311.57€	Buy
Kamagra	100mg	20 Pills	86.09€ 81.99€	Buy
Kamagra Soft Tabs	100mg	20 Pills	79.79€ 75.99€	Buy
Viagra Generic	50mg	180 + 8 Pills	158.82€ 151.26€	Buy
Kamagra Polo	100mg	84 + 4 Pills	244.49€ 232.85€	Buy
Kamagra	100mg	84 + 6 Pills	264.44€ 251.85€	Buy
Viagra Generic	150mg	30 + 2 Pills	72.32€ 68.88€	Buy
Viagra Generic	50mg	20 Pills	40.52€ 38.59€	Buy
Viagra Generic	100mg	360 + 10 Pills	330.21€ 314.49€	Buy
Kamagra Oral Jelly	100mg	110 + 9 Sachets	334.87€ 318.92€	Buy
Viagra Generic	150mg	270 + 10 Pills	326.61€ 311.06€	Buy
Viagra Generic	200mg	180 + 10 Pills	277.56€ 264.34€	Buy
Viagra Generic	150mg	120 + 8 Pills	177.58€ 169.12€	Buy

their partner, (vi) thoughts on administering the film formulation, (vii) comparison with the tablets, and (viii) efficacy and adverse reaction.

5. Warnings and Precautions

These results, shown in , indicate the robust performance of the sildenafil ODF across a range of manufacturing conditions. In addition, the water content stayed in a tight range regardless of the film casting parameters, and this remains true of the packaged product even after 3 weeks at 60°C. ED is defined as the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance [Citation76,Citation79–81]. ED still prevails as an unprecedented diagnosis and undertreated condition that contributes sildenafil pills to increased physical and psychosocial burden. It negatively impacts the wellbeing, relationships, and health-related quality of life (HR-QoL) of patients and their partners [Citation82,Citation83], and thus, any treatment interventions that substantially revive sexual function have the prospect to reinforce patient health and overall HR-QoL.

5.1. Bioequivalence and stability testing

ED may present with clinically relevant forms but also subclinical conditions deserving medical attention. Worldwide, various forms of ED are diagnosed in up to 150 million men and it has been projected to surge to 322 million cases by 2025. ED has affected 52% of men in the age group of 40 and 70 years and 70% of men above 70 years [Citation84–87]. The primary risk factors include diabetes mellitus, hypertension, and hyperlipidemia and modifiable risk factors like obesity, physical inactivity, alcoholism, and cigarette smoking [Citation88–90]. In addition, there is increasing evidence that ED can be considered as the perfect gender-dependent (early) biomarker of non-communicable diseases (NCDs) including peripheral vascular disease and cardiovascular disease, with a heightened risk of cardiovascular mortality as largely demonstrated by epidemiological studies [Citation91]. Of all the participants, 61.5% of the patients who switched from tablets to

12. Sildenafil Oral Film - Clinical Pharmacology

Till date, the PDE5 inhibitors approved for the treatment of ED by the US Food and Drug Administration and European Union (EU) include sildenafil, tadalafil, vardenafil, and avanafil [Citation82,Citation96–98]. Sildenafil citrate, the first-in-class PDE5-I, is the most potent and selective inhibitor of cGMP-specific PDE5. Since its launch for the treatment of ED in 1998 in the market, there has been a well-established evidence base for its effectiveness and safety of sildenafil. It is the most efficacious drug, from a vascular perspective, among other PDE5-Is [Citation99]. This established efficacy of sildenafil in ED is irrespective of confounding factors including age, baseline severity, or etiology of ED [Citation100].

12.1 Sildenafil Oral Film Mechanism of Action

Although, sildenafil ODT is marketed at various strengths of 25, 50, and 100 mg, 50 mg is the recommended dose for most of the patients with directions to be approximately taken one hour before sexual activity. The dose can be titrated to a maximum of 100 mg or reduced to 25 mg considering individual patient’s needs, tolerability, and efficacy. Headache and flushing are the most commonly reported side effects [Citation101]. Sildenafil is supplied in both solid film-coated tablet (FCT) and orodispersible tablet formulations. The sildenafil ODT and ODFs are made available through implementation of innovative manufacturing technologies [Citation8,Citation102]. film quoted that storage and portability

• Sildenafil strips are an alternative to traditional pill forms.
• The strips dissolve quickly, eliminating need for water to swallow.
• They are convenient for on-the-go use and discreet consumption.
• Possible side effects include headache, flushing, and dizziness.
• Sildenafil strips should be used approximately one hour before activity.
• Not suitable for individuals with certain health conditions; consult a doctor.
• They are typically used in men aged 18 and above.
• The medication works by increasing blood flow to the penis.
• Sildenafil strips can be part of a broader erectile dysfunction treatment plan.
• Side effects may vary depending on individual health status.
• Erectile response may improve with proper use and dosing.
• They are available through licensed pharmacies and online sources.

were improved and were comfortable during consumption.

Detection in biological fluids

It is also offered as chewable tablets and an orally soluble orodispersible film formulation [Citation82]. conducted a randomized clinical trial that reported bioequivalence of sildenafil ODT with or without water compared to marketed film-coated tablets. This study also identified the effect of food on the release pattern of drug and demonstrated the benefits of the administration of sildenafil ODT on empty stomach [Citation103]. examined and reported the bioequivalence of sildenafil citrate ODF and FCT with and without water in 2 randomized crossover studies [Citation75]. Owing to its unique pharmacological characteristics, quick disintegration within seconds, the novel sildenafil ODF is widely prescribed and preferred among ED patients. The study reported that most of their patients felt more at ease

Step	Instruction	Precautions
Dose Placement	Place strip under tongue or inside cheek	Avoid swallowing immediately
Expect Dissolution	Wait until fully dissolved before eating/drinking	No water during dissolution
Timing Before Activity	Take 15-30 minutes before anticipated sexual activity	Avoid heavy meals near dosing
Storage	Keep strips in a cool, dry place, away from children	Keep away from moisture
Overdose Warning	Do not exceed prescribed dose	Seek medical attention if overdose suspected

(69.2% who swapped from tablets to film and 75.0% belonged to the

Mechanism of action

To further demonstrate the possibility to safely store the drug in the pocket, maximizing the need for a discreet treatment, a stress test has been conducted on sildenafil ODF by exposing it to elevated temperatures (60 degrees Celsius) for three weeks, mimicking extreme storage conditions and followed by evaluation of its physical and chemical stability. Ensuring the stability of pharmaceutical products is crucial to maintain their efficacy, safety, and quality throughout their shelf life, particularly critical in the case of sildenafil ODF. This test was conducted in Kyukyu Pharmaceutical Co., Ltd, Toyama Plant, Japan. A thin pale red-colored ODF containing 50 mg sildenafil was formulated to dissolve in the oral cavity. Three batches of samples were subjected to a stability study at 60°C stress for three weeks.

naresh kumar prasad

Subsequently, they were assessed for the amount of API assay (95.0%−105.0% of labeled amount), degradation, disintegration, dissolution rate (over 80% for 45 mm), and water content. All the test items of this stability study met the specifications and showed negligible differences between the samples. The amount of degradation products demonstrated an increasing trend over time in all conditions, but all met the required specification. The purity testing for the degradation product (0.2% or less) showed significant results (p value < 0.05) at initial and 60°C in all the three samples. The process was evaluated across a range of manufacturing conditions, and all intermediates and sildenafil ODF showed reliable performance that yielded a consistent product meeting all specifications at release and after three weeks of storage under stressed conditions. prescribed film-only category) and more comfortable

Indications & Uses

Indeed, ED can be considered a symptom for underlying NCD that may be explained as the classical canary in the coalmine [Citation92]. The management of ED includes the identification and control of risk factors and appropriate pharmacological and non-pharmacological therapy. The treatment strategies undoubtedly can reduce the initial symptoms and halt the progression of the disease. Some of the treatment approaches encompass psychosexological strategies, intraurethral or intracavernosal alprostadil self-injections, vacuum-assisted erection devices, low-intensity extracorporeal shock wave treatment, and penile implants. Nevertheless, after the efforts to modify unhealthy lifestyle and control risk factors and comorbidities, pharmacological management with oral PDE5-Is stays as the first-line treatment choice for ED because of its proven efficacy and better safety profile [Citation8].

Flavor Profile

The PDE5-Is inhibit the PDE5 enzyme concentrated in the smooth muscle cells in the blood vessels [Citation93]. Due to this inhibition, PDE5-Is prevent the enzyme-initiated degradation of cyclic guanosine monophosphate (cGMP), which causes elevation of cGMP in the vascular smooth muscle. Elevated cGMP levels sildenafil 100 mg tab lead to dilatation of the blood vessels due to phosphorylation of various downstream effector molecules, ensuring relaxation of smooth muscles [Citation94]. Inhibiting PDE5 produces a dilatation of the penile arteries that leads to a more prolonged and stable erection. Futhermore, PDE5-Is improve endothelial function and decrease apoptosis of smooth muscle cells in the corpus cavernosum [Citation93,Citation95]. with the film (61.5% who switched

Parameter	Description	Typical Values	Notes
Absorption Time	Time to reach peak plasma levels	15-30 minutes	Faster than tablets
Peak Plasma Concentration	Max concentration after dose	120-250 ng/mL	Varies with dose
Half-life	Time for plasma levels to reduce by half	3-5 hours	Limits dosing frequency
Bioavailability	Percentage of dose reaching systemic circulation	Approx. 80%	Enhanced via mucosal absorption

from tablets to film and 66.7% belonged to the prescribed film-only category).

Ingredient	Function	Concentration	Notes
Sildenafil Citrate	Active pharmaceutical ingredient	25 mg or 50 mg	Common doses in oral strips
Sweeteners	Improve taste	Variable	Sucralose, aspartame
Flavorings	Enhance flavor	Natural/Artificial	Mint, strawberry, citrus
Binders	Maintain structure	Hydroxypropyl methylcellulose	Ensures strip integrity
Stabilizers	Preserve shelf life	Ascorbic acid	Prevent degradation

Site Operator

Fabienne Heyne
[email protected]

Corporate Design

Silvio Ketterer Visuelle Gestaltung
www.silvioketterer.ch

Website Programming

RHOdesign
www.rhodesign.ch

Photography

Angelika Annen
www.angelikaannen.ch